Skip to main content

Gabriel India Q2 Revenue Rises to ₹1,399 Crore From ₹1,140 Crore YoY

Gabriel India recorded Q2 revenue of ₹1,399 crore, representing a 22.72% YoY increase from ₹1,140 crore. The revenue growth highlights healthy demand from automotive OEMs for ride-control solutions.

Author Image
Sahi Markets
Published: 30 Oct 2026, 09:18 PM IST (1 hour ago)
Last Updated: 30 Oct 2026, 09:18 PM IST (1 hour ago)
2 min read
Reviewed by Arpit Seth

Market snapshot: Gabriel India Limited reported a strong top-line growth in its Q2 financial results, with quarterly revenue expanding to ₹1,399 crore compared to ₹1,140 crore in the corresponding period of the previous year. The performance demonstrates sustained operational demand across the auto ancillary sector.

Data Snapshot

  • Q2 revenue reached ₹1,399 crore compared to ₹1,140 crore in the prior-year period.
  • Year-on-year revenue expansion stood at 22.72% for the quarter.

What's Changed

  • Quarterly revenue increased to ₹1,399 crore from ₹1,140 crore YoY (derived: ≈22.72% YoY growth).

Key Takeaways

  • Top-line revenue delivered a solid 22.72% YoY growth to reach ₹1,399 crore in Q2.
  • The increase reflects stable component off-take across domestic commercial and passenger vehicle OEM customers.
  • Inorganic partnerships in seating assemblies and automotive electronics complement ongoing core business growth.

SAHI Perspective

Gabriel India's Q2 top-line results underline strong market positioning within the domestic auto component ecosystem. Generating ₹1,399 crore in quarterly revenue indicates strong OEM volume pull and steady product utilization across ride control product lines.

Market Implications

The steady revenue trajectory reinforces market confidence in auto component suppliers benefiting from domestic vehicular build rates. Top-line expansion provides operating efficiency to support capital outlays for newly formed joint ventures.

Trading Signals

Market Bias: Bullish

Solid 22.72% YoY quarterly revenue growth to ₹1,399 crore provides a positive top-line signal for near-term fundamental sentiment.

Overweight: Auto Ancillaries, Automobiles

Trigger Factors:

  • Sustained quarterly dispatch schedules from major vehicle OEMs
  • Raw material cost volatility affecting overall gross margin retention
  • Commercial integration and ramp-up of newly incorporated joint venture entities

Time Horizon: Near-term (0-3 months)

Industry Context

India's auto ancillary sector continues to benefit from robust vehicular manufacturing cycles and rising localized component integration. Automotive suppliers with established OEM integration are capitalizing on higher content value per vehicle.

Key Risks to Watch

  • Volatilities in raw steel and specialized alloy prices impacting production costs
  • Potential cyclical shifts in commercial or passenger vehicle production volumes
  • Execution and ramp-up timelines associated with new joint venture projects

Recent Developments

In October 2026, Gabriel India incorporated Faurecia Anand Seating India Private Limited, a joint venture with Faurecia Automotive Seating India Private Limited (FORVIA), to manufacture automotive seating systems. In August 2026, the company executed definitive agreements to acquire a 30% minus one share stake in HL Klemove India Private Limited to expand into ADAS and automotive electronics technologies.

Closing Insight

Gabriel India's strong Q2 top-line expansion demonstrates robust core business health, while strategic joint ventures in seating and vehicle electronics support broader long-term diversification.

High Performance Trading with SAHI.

Disclaimer: This news section may include AI-generated or AI-assisted news, summaries, drafts, or insights. All content is subject to human review before publication. While we aim for accuracy, readers should independently verify information before relying on it.

Open Free Account

Frequently Asked Questions (FAQs)

All topics

Add Sahi as a Preferred Source on Google

Click the link, confirm the box next to sahi.com is checked — ignore any other results.